Literature DB >> 8798609

Role of residue 99 at the S2 subsite of factor Xa and activated protein C in enzyme specificity.

A R Rezaie1.   

Abstract

It is thought that only a limited number of residues in the extended binding pocket of coagulation proteases are critical for substrate and inhibitor specificity. A candidate residue from the crystal structures of thrombin and factor Xa (FXa) that may be critical for specificity at the S2 subsite is residue 99. Residue 99 is Tyr in FXa and Thr in activated protein C (APC). To determine the role of residue 99 in S2 specificity, a Gla-domainless mutant of protein C (GDPC) was prepared in which Thr99 was replaced with Tyr of FXa. GDPC T99Y bound Ca2+ and was activated by the thrombin-thrombomodulin complex normally. The T99Y mutant, similar to FXa, hydrolyzed the chromogenic substrates with a Gly at the P2 positions. This mutant was also inhibited by antithrombin (AT) (k2 = 4.2 +/- 0.2 x 10(1) M-1 s-1), and heparin accelerated the reaction >350-fold (k2 = 1.5 +/- 0.1 x 10(4) M-1 s-1). The T99Y mutant, however, did not activate prothrombin but inactivated factor Va approximately 2-fold better than wild type. To try to switch the specificity of FXa, both Tyr99 and Gln192 of FXa were replaced with those of APC in the Gla-domainless factor X (GDFX Y99T/Q192E). This mutant was folded correctly as it bound Ca2+ with a similar affinity as GDFX and was also activated by the Russell's viper venom at similar rate, but it cleaved the chromogenic substrates with a Gly at the P2 positions poorly. The mutant, instead, cleaved the APC-specific chromogenic substrates efficiently. The Y99T/Q192E mutant became resistant to inhibition by AT in the absence of heparin but was inhibited by AT almost normally in the presence of heparin (k2 = 3.4 +/- 0.5 x 10(5) M-1 s-1). The Y99T/Q192E mutant did not inactivate factor Va, and prothrombin activation by this mutant was impaired. These results indicate that 1) residue 99 is critical for enzyme specificity at the S2 subsite, 2) a role for heparin in acceleration of FXa inhibition by AT may involve the S2-P2 modulation, and 3) the exchange of residues 99 and 192 in FXa and APC may switch the enzyme specificity with the chromogenic substrates and inhibitors but not with the natural substrates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798609     DOI: 10.1074/jbc.271.39.23807

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Identification of exosite residues of factor Xa involved in recognition of PAR-2 on endothelial cells.

Authors:  Chandrashekhara Manithody; Likui Yang; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-03-15       Impact factor: 3.162

2.  Engineering the substrate and inhibitor specificities of human coagulation Factor VIIa.

Authors:  Katrine S Larsen; Henrik Østergaard; Jais R Bjelke; Ole H Olsen; Hanne B Rasmussen; Leif Christensen; Birthe B Kragelund; Henning R Stennicke
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

3.  Gly197Arg mutation in protein C causes recurrent thrombosis in a heterozygous carrier.

Authors:  Yeling Lu; Hemant Giri; Bruno O Villoutreix; Qiulan Ding; Xuefeng Wang; Alireza R Rezaie
Journal:  J Thromb Haemost       Date:  2020-04-09       Impact factor: 5.824

4.  Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.

Authors:  Likui Yang; Chandrashekhara Manithody; Shabir H Qureshi; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

5.  Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.

Authors:  David T Berg; Bruce Gerlitz; Jing Shang; Tommy Smith; Paula Santa; Mark A Richardson; Ken D Kurz; Brian W Grinnell; Ken Mace; Bryan E Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

6.  Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.

Authors:  Soumendra Rana; Likui Yang; Seyed Mahdi Hassanian; Alireza R Rezaie
Journal:  J Cell Biochem       Date:  2012-03       Impact factor: 4.429

Review 7.  Activated protein C action in inflammation.

Authors:  Pranita P Sarangi; Hyun-wook Lee; Minsoo Kim
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

8.  Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants.

Authors:  K P Hopfner; H Brandstetter; A Karcher; E Kopetzki; R Huber; R A Engh; W Bode
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

9.  Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.

Authors:  Likui Yang; Alireza R Rezaie
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

10.  Role of P2 glycine in determining the specificity of antithrombin reaction with coagulation proteases.

Authors:  Likui Yang; Shabir H Qureshi; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Biochem Biophys Res Commun       Date:  2009-08-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.